10.1038/s41467-020-18324-9 [DOI] [PMC free article] [PubMed] [Google Scholar] Tanabe S, OBrien J, Tollefsen KE et al (2022) Reactive oxygen species in the adverse outcome pathway framework: toward creation of harmonized consensus key events
Wolters Kluwer About Wolters Kluwer is a global provider of professional information, software solutions, and services for clinicians, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors
doi: 10.1080/1028415X.2020.1764292 [DOI] [PubMed] [Google Scholar] 215.Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis GA, Elkins CA, et al
The drug uses the active ingredient tirzepatide and was approved by the FDA in May 2022 for type 2 diabetes
The side effects of semaglutide will vary depending on the individual
Sixth, while the FAERS database provides valuable insights, exclusion of international pharmacovigilance databases such as the EudraVigilance or WHO VigiBase limits global generalizability, though accessibility constraints justify this approach